What Is VIP (Vasoactive Intestinal Peptide)?
Also known as: Aviptadil, VIP nasal spray
Vasoactive intestinal peptide (VIP) is a 28-amino-acid neuropeptide found throughout the gut, lungs, brain and immune system. It relaxes smooth muscle, dilates blood vessels, and shifts immune signaling away from inflammation — a broad regulatory hormone rather than a targeted drug.
It is best known in two contexts: as the final stage of the Shoemaker protocol for chronic inflammatory response syndrome (mold illness), given as a compounded nasal spray; and as aviptadil, an IV formulation studied in pulmonary hypertension and COVID-19 respiratory failure.
What is VIP (Vasoactive Intestinal Peptide) studied for?
- •CIRS / mold illness symptom resolution (nasal spray protocols)
- •Pulmonary arterial hypertension and ARDS (aviptadil trials)
- •Neuroprotection and circadian regulation
- •Autoimmune and inflammatory conditions (animal models)
Side effects & safety
Flushing, low blood pressure, palpitations and headache from vasodilation; nasal irritation with spray use. Protocols typically require lab screening (lipase, MMP-9) before starting.
Legal & approval status
Not FDA-approved; available as a compounded nasal spray by prescription in the US. Aviptadil is approved in some countries for erectile dysfunction (combined) and investigational for respiratory indications.
Typical dosing at a glance
Related peptides
Educational overview based on published research and commonly reported community protocols — not medical advice, and not an endorsement of any compound. Consult a licensed healthcare provider.